Orgenesis Inc. Common Stock
ORGS
ORGS was delisted on the 18th of October, 2024.
18 hedge funds and large institutions have $932K invested in Orgenesis Inc. Common Stock in 2024 Q2 according to their latest regulatory filings, with 4 funds opening new positions, 3 increasing their positions, 5 reducing their positions, and 2 closing their positions.
100% more first-time investments, than exits
New positions opened: 4 | Existing positions closed: 2
13% more funds holding
Funds holding: 16 → 18 (+2)
28% less capital invested
Capital invested by funds: $1.3M → $932K (-$365K)
40% less repeat investments, than reductions
Existing positions increased: 3 | Existing positions reduced: 5
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
XT
XTX Topco
George Town,
Cayman Islands
|
+$8.54K |
| 2 |
VF
Virtu Financial
New York
|
+$6.35K |
| 3 |
State Street
Boston,
Massachusetts
|
+$5.89K |
| 4 |
UBS Group
Zurich,
Switzerland
|
+$3.29K |
| 5 |
TRCT
Tower Research Capital (TRC)
New York
|
+$331 |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
BlackRock
New York
|
-$23.8K |
| 2 |
Vanguard Group
Malvern,
Pennsylvania
|
-$7.8K |
| 3 |
Renaissance Technologies
New York
|
-$2.68K |
| 4 |
Geode Capital Management
Boston,
Massachusetts
|
-$2.56K |
| 5 |
CAL
Capital Advisors Ltd
Shaker Heights,
Ohio
|
-$1K |
ORGS Hedge Fund Activity: Q2 2024 in Review
18 of the 6,925 institutional investors tracked by Wall St. Rank reported a position in Orgenesis Inc. Common Stock (ORGS) for Q2 2024, worth a combined $932K — down 28% from $1.3M a quarter earlier.
Buyers outnumbered sellers: 4 funds opened new ORGS positions and 2 closed out — a net gain of 2 holders — while 3 added to existing stakes and 5 trimmed.
The largest buyer was XTX Topco, opening a new position worth an estimated $8.54K. The largest seller was BlackRock, cutting an estimated $23.8K.
- 18 institutional investors held Orgenesis Inc. Common Stock (ORGS) as of Q2 2024, up from 16 in Q1 2024.
- Funds reported $932K of Orgenesis Inc. Common Stock stock for Q2 2024, down 28% quarter-over-quarter.
- 4 funds opened new Orgenesis Inc. Common Stock positions in Q2 2024 and 2 closed out, a net change of +2 holders.
- The largest Orgenesis Inc. Common Stock buyer in Q2 2024 was XTX Topco, an estimated $8.54K added.
- The largest Orgenesis Inc. Common Stock seller in Q2 2024 was BlackRock, an estimated $23.8K sold.
Based on aggregated 13F filings for Q2 2024.